Bg pattern

DUAKLIR GENUAIR 340/12 micrograms inhalation powder

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use DUAKLIR GENUAIR 340/12 micrograms inhalation powder

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Duaklir Genuair 340micrograms/12micrograms inhalation powder

aclidinium/formoterol fumarate dihydrate

Read this package leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this package leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this package leaflet. See section 4.

Contents of the package leaflet

  1. What is Duaklir Genuair and what is it used for
  2. What you need to know before you start using Duaklir Genuair
  3. How to use Duaklir Genuair
  4. Possible side effects
  5. Storing Duaklir Genuair
  6. Package contents and further information

Instructions for use

1. What is Duaklir Genuair and what is it used for

What is Duaklir Genuair

This medicine contains two active substances called aclidinium and formoterol fumarate dihydrate. Both belong to a group of medicines called bronchodilators. Bronchodilators work by relaxing the muscle in your airways, which helps to open up the airways and makes it easier for you to breathe. The Genuair inhaler delivers the active substances directly into your lungs when you inhale.

What is Duaklir Genuair used for

Duaklir Genuair is used in adult patients who have difficulty breathing due to a lung disease called chronic obstructive pulmonary disease (COPD), in which the airways and air sacs in the lungs are damaged or blocked. By opening up the airways, the medicine helps to relieve symptoms such as difficulty breathing. Regular use of Duaklir Genuair will reduce the effects of COPD on your daily life.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you start using Duaklir Genuair

Do not use Duaklir Genuair:

  • if you are allergic to aclidinium, formoterol fumarate dihydrate, or any of the other ingredients of this medicine (listed in Section 6).

Warnings and precautions

Talk to your doctor, pharmacist, or nurse before starting to use Duaklir Genuair if you have any of the following symptoms or diseases:

  • If you have asthma. This medicine should not be used to treat asthma.
  • If you have heart problems.
  • If you have epilepsy.
  • If you have thyroid disorders (thyrotoxicosis).
  • If you have a tumor in an adrenal gland (pheochromocytoma).
  • If you have difficulty urinating or problems due to an enlarged prostate.
  • If you have a eye condition called narrow-angle glaucoma, which causes high pressure in the eye.

Stop using Duaklir Genuair and seek immediate medical help if you experience any of the following symptoms

  • If you notice sudden tightness in the chest, coughing, wheezing, or difficulty breathing immediately after using the medicine. See section 4.

Duaklir Genuair is used as a maintenance treatment (long-term) for COPD. This medicine should not be used to treat a sudden attack of difficulty breathing or wheezing.

If your usual COPD symptoms (difficulty breathing, wheezing, or coughing) do not improve or worsen during treatment with Duaklir Genuair, you should continue using the medicine but you should also see your doctor as soon as possible so that they can determine if you need another medication.

If you see halos around lights or colored images, have eye pain or discomfort, or experience temporary blurred vision, see your doctor as soon as possible.

Dry mouth has been observed with medicines like Duaklir Genuair. In the long term, dry mouth may be associated with tooth decay, so it is important that you take care of your oral hygiene.

Children and adolescents

Duaklir Genuair should not be used in children or adolescents under 18 years of age.

Using Duaklir Genuair with other medicines

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines. If you use Duaklir Genuair with other medicines, the effect of Duaklir Genuair or the other medicines may be altered.

Tell your doctor or pharmacist if you are taking:

  • Any medicine that may be similar to Duaklir Genuair for the treatment of difficulty breathing.
  • Medicines that lower the level of potassium in the blood. These include:
  • oral corticosteroids (such as prednisolone),
  • diuretics (such as furosemide or hydrochlorothiazide),
  • certain medicines used to treat respiratory diseases (such as theophylline).
  • Medicines called beta-blockers that may be used to treat high blood pressure and other heart conditions (such as atenolol or propranolol) or to treat glaucoma (such as timolol).
  • Medicines that may cause a type of change in the electrical activity of the heart called "prolongation of the QT interval" (which is seen on an electrocardiogram). These include medicines for the treatment of:
  • depression (such as monoamine oxidase inhibitors or tricyclic antidepressants),
  • bacterial infections (such as erythromycin, clarithromycin, or telithromycin),
  • allergic reactions (antihistamines).

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor, pharmacist, or nurse for advice before using this medicine. You should not use Duaklir Genuair if you are pregnant or breastfeeding unless your doctor has recommended it.

Driving and using machines

Duaklir Genuair is unlikely to affect your ability to drive or use machines. However, some patients may experience blurred vision or dizziness. If you experience any of these side effects, do not drive or use machines until the dizziness has stopped and your vision has returned to normal.

Duaklir Genuair contains lactose

This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, contact them before taking this medicine.

3. How to use Duaklir Genuair

Follow the instructions for administration of this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist again.

  • The recommended dose is one inhalation in the morning and one inhalation in the evening.
  • You can use Duaklir Genuair at any time, before or after meals or drinks.
  • The effects of Duaklir Genuair last for 12 hours, so you should try to use Duaklir Genuair at the same time every morning and evening, as this will ensure that there is always enough medicine in your body to help you breathe more easily throughout the day and night. Also, using it at the same time every day will help you remember to use it.
  • The recommended dose can be used in elderly patients and in patients with kidney or liver problems. No dose adjustment is needed in these patients.
  • Duaklir Genuair is for inhalation use only.
  • Instructions for use:see the Instructions for Use at the end of this package leaflet for instructions on how to use the Genuair inhaler. If you are not sure how to use Duaklir Genuair, ask your doctor or pharmacist.

COPD is a long-term disease, and therefore Duaklir Genuair is for long-term use. The medicine should be used every day, twice a day, and not just when you have breathing problems or other symptoms of COPD.

If you use more Duaklir Genuair than you should

If you think you have used more Duaklir Genuair than you should, you are more likely to experience some of its side effects, such as blurred vision, dry mouth, nausea, tremors, headache, palpitations, or increased blood pressure; in this case, contact your doctor immediately or go to the nearest emergency room. Take the Duaklir Genuair package with you. You may need medical attention.

If you forget to use Duaklir Genuair

If you forget a dose of Duaklir Genuair, use it as soon as possible and use the next dose at the usual time. Do not use a double dose to make up for forgotten doses.

If you stop using Duaklir Genuair

This medicine is for long-term treatment. If you want to stop treatment, talk to your doctor first, as your symptoms may worsen.

If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop using the medicine and contact your doctor immediately if you:

  • experience swelling of the face, throat, lips, or tongue (with or without difficulty breathing or swallowing), hives, or severe itching of the skin (urticaria), as these may be signs of an allergic reaction. The frequency of this reaction cannot be estimated from the available data.
  • experience tightness in the chest, coughing, wheezing, or difficulty breathing immediately after using the medicine. These may be signs of a condition called "paradoxical bronchospasm", which is a severe and prolonged contraction of the muscle in the airways immediately after treatment with a bronchodilator. This reaction may occur rarely (affects 1 in 1,000 people).

Some side effects can be serious:if you experience any of these side effects, tell your doctor immediately.

Uncommon(may affect up to 1 in 100 people)

  • Weakness or muscle spasms and/or abnormal heart rhythm, as these may be signs of a low level of potassium in the blood
  • Fatigue, increased thirst, and/or need to urinate more frequently than usual, as these may be signs of a high level of sugar in the blood
  • Palpitations, as this may be a sign of an abnormally fast or irregular heart rhythm

Rare(may affect up to 1 in 1,000 people)

  • Sudden difficulty breathing or swallowing, swelling of the tongue, throat, lips, or face, rash, and/or skin itching; these may be signs of an allergic reaction

Other side effects that may occur when using Duaklir Genuair:

Common(may affect up to 1 in 10 people)

  • Combination of sore throat and increased mucus; these may be signs of nasopharyngitis
  • Headache
  • Pain when urinating and/or frequent urination; these may be signs of a urinary tract infection
  • Coughing
  • Diarrhea
  • Stuffy or runny nose, increased mucus, and/or pain or pressure in the cheeks or forehead; these may be symptoms of sinusitis
  • Dizziness
  • Muscle cramps
  • Feeling sick (nausea)
  • Difficulty sleeping
  • Dry mouth
  • Muscle pain
  • Abscess (infection) of the gum
  • High levels in the blood of a protein that is found in muscle tissue and is called creatine phosphokinase
  • Tremors
  • Anxiety

Uncommon

  • Fast heart rate (tachycardia)
  • Abnormal or irregular heart rhythm (cardiac arrhythmias)
  • Chest pain or discomfort (angina pectoris)
  • Blurred vision
  • Changes in the tone of the voice (dysphonia)
  • Difficulty urinating or feeling that the bladder is not fully empty (urinary retention)
  • Abnormal electrocardiogram (prolongation of the QT interval) that may lead to an abnormal heart rhythm
  • Altered sense of taste (dysgeusia)
  • Sore throat
  • Inflammation of the mouth (stomatitis)
  • Increased blood pressure
  • Nervousness
  • Rash
  • Itching of the skin

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this package leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storing Duaklir Genuair

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the inhaler label, the inhaler case, and the inhaler bag after "EXP". The expiry date is the last day of the month shown.

This medicine does not require any special storage conditions.

Keep the Genuair inhaler protected in the closed bag until you start treatment.

Use within 60 days of opening the bag.

Do not use Duaklir Genuair if you notice that the package is damaged or shows signs of tampering.

Once you have used the last dose, the inhaler should be discarded. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Container Contents and Additional Information

Duaklir Genuair Composition

  • The active substances are aclidinium and formoterol fumarate dihydrate. Each delivered dose (the dose that comes out of the mouthpiece) contains 396 micrograms of aclidinium bromide equivalent to 340 micrograms of aclidinium and 11.8 micrograms of formoterol fumarate dihydrate.
  • The other component is lactose monohydrate (see the end of section 2 under the heading “Brimica Genuair contains lactose” for more information).

Appearance of the Product and Container Contents

Duaklir Genuair is a white or almost white inhalation powder.

The Genuair inhaler is a white device with an integrated dose indicator and an orange dosing button. The mouthpiece is covered by a removable orange protective cap. It is provided in a closed aluminum protective bag containing a desiccant sachet. After removing the inhaler from the bag, the bag and desiccant should be thrown away.

Available container sizes:

Container containing 1 inhaler with 30 doses.

Container containing 1 inhaler with 60 doses.

Container containing 3 inhalers with 60 doses each.

Only some container sizes may be marketed.

Marketing Authorization Holder

Covis Pharma Europe B.V.

Gustav Mahlerplein 2

1082MA Amsterdam

Netherlands

Manufacturer:

Industrias Farmacéuticas Almirall, S.A.

Ctra. de Martorell 41-61

08740 Sant Andreu de la Barca, Barcelona

Spain

You can request more information about this medication by contacting the local representative of the marketing authorization holder:

België/Belgique/Belgien

Covis Pharma Europe B.V.

Tel: 80013067

Lietuva

Covis Pharma Europe B.V.

Tel: 880000890

Text with contact information of Covis Pharma Europe BV including name, phone number, and address in Bulgaria

Luxembourg/Luxemburg

Covis Pharma Europe B.V.

Tel: 80024119

Ceská republika

Covis Pharma Europe B.V.

Tel: 800144474

Magyarország

Covis Pharma Europe B.V.

Tel.: 0680021540

Danmark

Zentiva Denmark ApS

Tlf: +45 787 68 400

Malta

Covis Pharma Europe B.V.

Tel: 80065149

Deutschland

Zentiva Pharma GmbH

Tel: +49 (0) 800 53 53 010

Nederland

Covis Pharma Europe B.V. Tel: 08000270008

Eesti

Covis Pharma Europe B.V

Tel: 8000100776

Norge

Zentiva Denmark ApS

Tlf: +47 219 66 203

Ελλáδα

Specialty Therapeutics IKE Τηλ: +30 213 02 33 913

Österreich

Covis Pharma Europe B.V.

Tel: 0800006573

España

Zentiva Spain S.L.U.

Tel: +34 931 815 250

Polska

Covis Pharma Europe B.V.

Tel.: 0800919353

France

Zentiva France

Tél: +33 (0) 800 089 219

Portugal

Zentiva Portugal, Lda

Tel: +351210601360

Hrvatska

Covis Pharma Europe B.V.

Tel: 08004300

România

Covis Pharma Europe B.V.

Tel: 0800410175

Ireland

Covis Pharma Europe B.V.

Tel: 1800937485

Slovenija

Covis Pharma Europe B.V.

Tel: 080083003

Ísland

Zentiva Denmark ApS

Sími: +354 539 0650

Slovenská republika

Covis Pharma Europe B.V.

Tel: 0800008203

Italia

Covis Pharma Europe B.V.

Tel: 800168094

Suomi/Finland

Zentiva Denmark ApS

Puh/Tel: +358 942 598 648

Κúπρος

Specialty Therapeutics IKE Τηλ: +30 213 02 33 913

Sverige

Zentiva Denmark ApS

Tel: +46 840 838 822

Latvija

Covis Pharma Europe B.V.

Tel: 80005962

United Kingdom (Northern Ireland)

Zentiva, k.s.

Tel: +44 (0) 800 090 2408

Date of Last Revision of this Leaflet:

Detailed information on this medication is available on the European Medicines Agency website: http://www.ema.europa.eu/.

Instructions for Use

This section contains information on how to use the Genuair inhaler. It is important that you read this information, as Genuair may work differently from inhalers you have used before. If you have any questions about how to use the inhaler, consult your doctor, pharmacist, or nurse.

The instructions for use are divided into the following sections:

  • How to Start
  • Step 1: Prepare Your Dose
  • Step 2: Inhale Your Medication
  • Additional Information

How to Start

Read these instructions for use before starting to use the medication

Familiarize yourself with the parts of your Genuair inhaler

Inhaler with orange and white color, mouthpiece, protective cap, and control window with dose indicator

Before Use:

  • Before the first use, open the closed bag and remove the inhaler. Dispose of the bag and the desiccant.
  • Do not press the orange button until you are ready to inhale a dose.
  • Remove the cap by gently pressing the arrows on either side (Figure B).

Auto-injector device held by two hands with arrow indicating press and remove

STEP 1: Prepare Your Dose

  1. Check the mouthpiece opening and make sure nothing is blocking it (Figure C).
  2. Check the control window (it should be red, Figure C).

Gray inhaler device with numeric indicator 60 and red button highlighted within an orange frame

  1. Hold the inhaler horizontally with the mouthpiece facing you and the orange button on top (Figure D).

Hand holding a white and orange auto-injector with thumb pressing the activation button

  1. Press the orange button down and all the way to load your dose (Figure E).

When you press the orange button down and all the way, the control window will change from red to green.

Make sure the orange button is up. Do not tilt it.

  1. Release the orange button (Figure F).

Make sure to release the button so that the inhaler can work correctly.

Two hands holding orange auto-injector devices showing the correct injection technique

Stop and Check:

  1. Make sure the control window is now green (Figure G).

Your medication is ready to be inhaled.

Go to “STEP 2: Inhale Your Medication”.

Silver auto-injector device with digital display showing the number 60 and a green indicator light

Figure G

What to Do If the Control Window Remains Red After Pressing the Button (Figure H).

Insulin device with screen showing the number 60 crossed out with a red diagonal cross

The dose is not prepared. Go back to “STEP 1 Prepare Your Dose” and repeat steps 1.1 to 1.6.

STEP 2: Inhale Your Medication

Read steps 2.1 to 2.7 completely before using. Do not tilt.

2.1 Keep the inhaler away from your mouth and exhale completely.Never exhale into the inhaler (Figure I).

Human mouth profile with black arrow indicating direction outward from the lips

2.2 Keep your head upright, place the mouthpiece between your lips, and close them tightly around the mouthpiece (Figure J).

Do not keep the orange button pressed while inhaling.

Hand holding a white and orange nasal inhaler near the right nostril with powder coming out

Figure J

2.3 Take a strong and deep breaththrough your mouth. Keep breathing in for as long as possible.

A “click” will let you know that you have inhaled correctly. Keep breathing in for as long as possible after hearing the “click”. Some patients may not hear the “click”. Use the control window to make sure you have inhaled correctly.

2.4 Remove the inhaler from your mouth.

2.5 Hold your breath for as long as possible.

2.6 Breathe out slowly away from the inhaler.

Some patients may experience a gritty sensation in the mouth or a slightly sweet or bitter taste. Do not inhale an extra dose if you do not notice any taste or feel anything after inhaling.

Stop and Check:

2.7 Make sure the control window is now red (Figure K). This means you have inhaled your medication correctly.

Insulin device with screen showing the number 60 and a red indicator button with arrow pointing

What to Do If the Control Window Remains Green After Inhaling (Figure L).

Inhaler device with digital display showing the number 60 crossed out with a prominent red cross

Figure L

This means you have not inhaled your medication correctly. Go back to “STEP 2 Inhale Your Medication” and repeat steps 2.1 to 2.7.

If the control window still does not change to red, you may have forgotten to release the orange button before inhaling, or you may not have inhaled strongly enough. If this happens, try again. Make sure you have released the orange button and that you have exhaled completely. Then take a strong and deep breath through the mouthpiece.

Please contact your doctor if the control window remains green after several attempts.

Put the protective cap back on the mouthpiece after each use (Figure M), to prevent contamination of the inhaler with dust or other materials. You must discard your inhaler if you lose the cap.

Auto-injector device with orange and white parts being assembled by gloved hands, arrow indicates direction

Additional Information:

What should you do if you accidentally load a dose?

Keep your inhaler with the protective cap in place until it is time to inhale your medication, then remove the cap and start at step 1.6.

How does the dose indicator work?

  • The dose indicator shows the total number of doses left in the inhaler (Figure N).
  • On the first use, each inhaler contains at least 60 or 30 doses, depending on the container size.
  • Each time a dose is loaded by pressing the orange button, the dose indicator moves slightly to the next number (50, 40, 30, 20, 10, or 0).

When should you get a new inhaler?

You should get a new inhaler:

  • If your inhaler appears to be damaged or loses its cap, or
  • When a red striped band appears on the dose indicator, this means you are approaching the last dose (Figure N), or
  • If your inhaler is empty (Figure O).

Drug delivery device with dose indicator showing the number 10 and a red striped band, arrows pointing to parts

How do you know if your inhaler is empty?

When the orange button does not fully return to its top position and remains stuck in a middle position, it has reached the last dose (Figure O). Even when the orange button is stuck, you can still inhale the last dose. After that, the inhaler cannot be used again and you should start using a new inhaler.

White and yellow auto-injector device with ergonomic shape and visible activation button, text

How should you clean the inhaler?

NEVER use water to clean the inhaler, as it could damage your medication.

If you want to clean your inhaler, simply wipe the outside of the mouthpiece with a dry cloth or paper towel.

Online doctors for DUAKLIR GENUAIR 340/12 micrograms inhalation powder

Discuss questions about DUAKLIR GENUAIR 340/12 micrograms inhalation powder, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80
0.0 (0)
Doctor

Daniel Cichi

Family medicine 24 years exp.

Dr Daniel Cichi is a family medicine doctor with over 20 years of clinical experience. He provides online consultations for adults, supporting patients with acute symptoms, chronic conditions, and everyday health concerns that require timely medical guidance.

His background includes work in emergency care, ambulance services, and family medicine, which allows him to assess symptoms quickly, identify warning signs, and help patients choose the safest next steps – whether that means home care, treatment adjustment, or in-person evaluation.

Patients commonly consult Dr Daniel Cichi for:

  • acute symptoms: fever, infections, flu-like illness, cough, sore throat, shortness of breath;
  • chest discomfort, palpitations, dizziness, fatigue, and blood pressure concerns;
  • digestive problems: abdominal pain, nausea, diarrhoea, constipation, reflux;
  • muscle, joint, and back pain, minor injuries, post-traumatic symptoms;
  • chronic conditions: hypertension, diabetes, high cholesterol, thyroid disorders;
  • review and interpretation of lab tests, imaging reports, and medical documents;
  • medication review and treatment adjustment;
  • medical advice while travelling or living abroad;
  • second opinions and guidance on whether in-person care is needed.
Dr Cichi’s consultations are structured and practical. He focuses on clear explanations, risk assessment, and actionable recommendations, helping patients understand their symptoms and make informed decisions about their health.
Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for DUAKLIR GENUAIR 340/12 micrograms inhalation powder?
DUAKLIR GENUAIR 340/12 micrograms inhalation powder requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in DUAKLIR GENUAIR 340/12 micrograms inhalation powder?
The active ingredient in DUAKLIR GENUAIR 340/12 micrograms inhalation powder is formoterol and aclidinium bromide. This information helps identify medicines with the same composition but different brand names.
How much does DUAKLIR GENUAIR 340/12 micrograms inhalation powder cost in pharmacies?
The average pharmacy price for DUAKLIR GENUAIR 340/12 micrograms inhalation powder is around 70.25 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures DUAKLIR GENUAIR 340/12 micrograms inhalation powder?
DUAKLIR GENUAIR 340/12 micrograms inhalation powder is manufactured by Covis Pharma Europe B.V.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of DUAKLIR GENUAIR 340/12 micrograms inhalation powder online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether DUAKLIR GENUAIR 340/12 micrograms inhalation powder is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to DUAKLIR GENUAIR 340/12 micrograms inhalation powder?
Other medicines with the same active substance (formoterol and aclidinium bromide) include BRIMICA GENUAIR 340/12 micrograms powder for inhalation, ANORO ELLIPTA 55 MCG/22 MCG INHALATION POWDER (SINGLE-DOSE), IPRATROPIUM BROMIDE/SALBUTAMOL GENETIC 0.5 mg/2.5 mg SOLUTION FOR NEBULIZER INHALATION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media